Angiotensin-II for vasoplegia following cardiac surgery.

Andrew J JohnsonWilliam TidwellAndrew McRaeC Patrick HensonAntonio Hernandez

Published in: Perfusion (2023)

The administration of angiotensin-II to vasoplegic patients following cardiac surgery was associated with increased mean arterial pressure, reduced norepinephrine dosages, and reduced dobutamine dosages.

Keyphrases

angiotensin ii
cardiac surgery
angiotensin converting enzyme
vascular smooth muscle cells
end stage renal disease
acute kidney injury
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes